Camelid nanobodies raised against an integral membrane enzyme, nitric oxide reductase

Protein Science

Volumn 18, Issue 3, 2009, Pages 619-628

  Conrath, Katja ^a,b   Pereira, Alice S ^c   Martins, Carlos E ^c   Timóteo, Cristina G ^c   Tavares, Pedro ^c   Spinelu, Silvia ^d   Kinne, Joerg ^e   Flaudrops, Christophe ^d   Cambillau, Christian ^d   Muyldermans, Serge ^a,b   Moura, Isabel ^c   Moura, Jose J G ^c   Tegoni, Mariella ^d   Desmyter, Aline ^d  

^a VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

^b DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

^c UNIVERSIDADE NOVA DE LISBOA   (Portugal)

^d Centre National de la Recherche Scientifique   (France)

^e CENTRAL VETERINARY RESEARCH LABORATORY   (United Arab Emirates)

Author keywords

Camelid antibodies; Nitric oxide reductase; Phage display; SPR; VHH domain

Indexed keywords

ANTIBODY; ASCORBIC ACID; CAMELID ANTIBODY; CYTOCHROME C OXIDASE; EPITOPE; IMMUNOGLOBULIN HEAVY CHAIN; MEMBRANE PROTEIN; NITRIC OXIDE REDUCTASE; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANIMAL CELL; ARTICLE; ARTIODACTYLA; CAMEL; COMPLEX FORMATION; CONTROLLED STUDY; CRYSTALLIZATION; ELECTRON TRANSPORT; ENZYME PURIFICATION; EPITOPE MAPPING; IMMUNIZATION; NONHUMAN; PHAGE DISPLAY; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN PURIFICATION; PROTEIN STRUCTURE; PSEUDOMONAS; PSEUDOMONAS NAUTICA; SEQUENCE ALIGNMENT; SURFACE PLASMON RESONANCE; X RAY DIFFRACTION;

CAMELIDAE; CAMELUS DROMEDARIUS;

EID: 61449174868     PISSN: 09618368     EISSN: 1469896X     Source Type: Journal    
DOI: 10.1002/pro.69     Document Type: Article

References (47)

1. Hamers-Casterman C, Atarhouch T, Muyldermans S, Robinson G, Hamers C, Songa EB, Bendahman N, Harriers R (1993) Naturally occurring antibodies devoid of light chains. Nature 363:446-448.
2. Muyldermans S, Cambillau C, Wyns L (2001) Recognition of antigens by single-domain antibody fragments: the superfluous luxury of paired domains. Trends Biochem Sci 26:230-235.
3. Dumoulin M, Last AM, Desmyter A, Decanniere K, Canet D, Larsson G, Spencer A, Archer DB, Sasse J, Muyldermans S, Wyns L, Redfield C, Matagne A, Robinson CV, Dobson CM (2003) A camelid antibody fragment inhibits the formation of amyloid fibrils by human lysozyme. Nature 424:783-788.
4. Dolk E, van der Vaart M, Lutje Hulsik D, Vriend G, de Haard H, Spinelli S, Cambillau C, Frenken. L, Verrips T (2005a) Isolation of llama antibody fragments for prevention of dandruff by phage display in shampoo. Appl Environ Microbiol 71:442-450.
5. Harrison RA, Hasson SS, Harmsen M, Laing GD, Conrath K, Theakston RD (2005) Neutralisation of venominduced haemorrhage by IgG from camels and llamas immunised, with viper venom and also by endogenous, non-IgG components in camelid sera. Toxicon 47: 364-368.
6. Saerens D, Frederix F, Reekmans G, Conrath K, Jans K, Brys L, Huang L, Bosnians E, Maes G, Borghs G, Muyldermans S (2005) Engineering camel single-domain antibodies and immobilization chemistry for human prostate-specific antigen sensing. Anal Chem. 77: 7547-7555.
7. Rothbauer U, Zolghadr K, Muyldermans S, Schepers A, Cardoso MC, Leonhardt H (2008) A versatile nanotrap for biochemical and functional studies with fluorescent fusion proteins. Mol Cell Proteomics 7:282-289.
8. Conrath KE, Lauwereys M, Galleni M, Matagne A, Frere JM, Kinne J, Wyns L, Muyldermans S (2001) Beta-lactamase inhibitors derived from single-domain antibody fragments elicited in the camelidae. Antimicrob Agents Chemother 45:2807-2812.
9. Cortez-Retamozo V, Lauwereys M, Hassanzadeh Gh G, Gobert M, Conrath K, Muyldermans S, De Baetselier P, Revets H (2002) Efficient tumor targeting by single-domain antibody fragments of camels. Int J Cancer 98: 456-462.
10. Aires da Silva F, Santa-Marta M, Freitas-Vieira A, Mascarenhas P, Barahona I, Moniz-Pereira J, Gabuzda D, Gonçalves J (2004) Camelized rabbit-derived VH singledomain intrabodies against Vif strongly neutralize HIV-i infectivity. J Mol Biol 340:525-542.
11. Harmsen MM, van. Solt CB, van Zijderveld-van Bemmel AM, Niewold TA, van Zijderveld FG (2006) Selection and optimization of proteolytically stable llama single-domain antibody fragments for oral immunotherapy. Appl Microbiol Biotechnol 72:544-551.
12. Desmyter A, Transue TR, Ghahroudi MA, Thi MH, Poortmans F, Hamers R, Muyldermans S, Wyns L (1996) Crystal structure of a camel single-domain VH antibody fragment in complex with lysozyme. Nat Struct Biol 3: 803-811.
13. Spinelli S, Frenken L, Bourgeois D, de Ron L, Bos W, Verrips T, Anguille C, Cambillau C, Tegoni M (1996) The crystal structure of a llama heavy chain, variable domain. Nat Struct Biol 3:752-757.
14. Decanniere K, Desmyter A, Lauwereys M, Ghahroudi MA, Muyldermans S, Wyns L (1999) A single-domain antibody fragment in complex with RNase A: non-canonical loop structures and nanomolar affinity using two CDR loops. Structure 7:361-370.
15. Decanniere K, Transue TR, Desmyter A, Maes D, Muyldermans S, Wyns L (2001) Degenerate interfaces in antigen-antibody complexes. J Mol Biol 313:473-478.
16. Desmyter A, Decanniere K, Muyldermans S, Wyns L (2001) Antigen specificity and high affinity binding provided by one single loop of a camel single-domain antibody. J Biol Chem 276:26285-26290.
17. Desmyter A, Spinelli S, Payan F, Lauwereys M, Wyns L, Muyldermans S, Cambillau C (2002) Three camelid VHH domains in complex with porcine pancreatic alpha-amylase. Inhibition and versatility of binding topology. J Biol Chem 277:23645-23650.
18. Renisio JG, Perez J, Czisch M, Guenneugues M, Bornet O, Frenken L, Cambillau C, Darbon H (2002) Solution structure and backbone dynamics of an antigen-free heavy chain variable domain (VHH) from. Llama. Proteins 47:546-555.
19. Loris R, Marianovsky I, Lah J, Laeremans T, Engelberg-Kulka H, Glaser G, Muyldermans S, Wyns L (2003) Crystal structure of the intrinsically flexible addiction antidote MazE. J Biol Chem 278:28252-28257.
20. Spinelli S, Desmyter A, Frenken L, Verrips T, Tegoni M, Cambillau C (2004) Domain swapping of a llama VHH domain builds a crystal-wide beta-sheet structure. FEBS Lett 564:35-40.
21. Dolk E, van Vliet C, Perez JM, Vriend G, Darbon H, Ferrât G, Cambillau C, Frenken LG, Verrips T (2005) Induced refolding of a temperature denatured llama heavy-chain antibody fragment by its antigen. Proteins 59:555-564-
22. Spinelli S, Desmyter A, Verrips CT, de Haard HJ, Moineau S, Cambillau C (2006) Lactococcal bacteriophage p2 receptor-binding protein structure suggests a common ancestor gene with bacterial and mammalian viruses. Nat Struct Mol Biol 13:85-89.
23. Spinelli S, Frenken LG, Hermans P, Verrips T, Brown K, Tegoni M, Cambillau C (2000) Camelid heavy-chain variable domains provide efficient combining sites to haptens. Biochemistry 39:1217-1222.
24. Spinelli S, Tegoni M, Frenken L, van Vliet C, Cambillau C (2001) Lateral recognition of a dye hapten by a llama VHH domain. J Mol Biol 311:123-129.
25. Einsle O, Kroneck. PM (2004) Structural, basis of denitrification. Biol Chem 385:875-883.
26. Fulop V, Moir JW, Ferguson SJ, Hajdu J (1995) The anatomy of a afunctional enzyme: structural basis for reduction of oxygen to water and synthesis of nitric oxide by cytochrome cd1. Cell 81:369-377.
27. Nurizzo D, Cutruzzola F, Arese M, Bourgeois D, Brunori M, Cambillau C, Tegoni M (1998) Conformational changes occurring upon reduction and NO binding in nitrite reductase from Pseudomonas aeruginosa. Biochemistry 37:13987-13996.
28. Brown K, Djinovic-Carugo K, Haltia T, Cabrito I, Saraste M, Moura JJG, Moura I, Tegoni M, Cambillau C (2000) Revisiting the catalytic CuZ cluster of nitrous oxide (N2O) reductase - Evidence of a bridging inorganic sulfur. J Biol Chem 275:41133-41136.
29. Bertero MG, Rothery RA, Palak M, Hou C, Lim D, Blasco F, Weiner JH, Strynadka NC (2003) Insights into the respiratory electron transfer pathway from the structure of nitrate reductase A. Nat Struct Biol 10:681-687.
30. Haltia T, Brown. K, Tegoni M, Cambillau C, Saraste M, Mattila K, Djinovic-Carugo K (2003) Crystal structure of nitrous oxide reductase from Paracoccus denitrificans at 1.6 angstrom resolution. Biochem J 369:77-88.
31. Jormakka M, Richardson D, Byrne B, Iwata S (2004) Architecture of NarGH reveals a structural, classification of Mo-bisMGD enzymes. Structure 12:95-104.
32. Iwata S, Ostermeier C, Ludwig B, Michel H (1995) Structure at 2.8 A resolution of cytochrome c oxidase from Paracoccus denitrificans. Nature 376:660-669.
33. Forte E, Urbani A, Saraste M, Sarti P, Brunori M, Giuffre A (2001) The cytochrome cbb3 from Pseudomonas stutzen displays nitric oxide reductase activity. Eur J Biochem 268:6486-6491.
34. Rabat EA, Wu TT, Perry HM, Gottesmann KS, Foeller C (1991) in NH Publication no. 91-3242, 5th Ed., U.S. Department of Health and Human Services.
35. Fan. SF, Kao CY (1992) Three-dimensional structure of an Fv from a human IgM immunoglobulin. Eur J Pharmacol 229:259-263.
36. Hunte C, Michel H (2002) Crystallisation of membrane proteins mediated by antibody fragments. Curr Opin Struct Biol. 12:503-508.
37. Rothlisberger D, Pos KM, Pluckthun A (2004) An antibody library for stabilizing and crystallizing membrane proteins selecting binders to the citrate carrier CitS. FEBS Lett 564:340-348.
38. Rasmussen SG, Choi HJ, Rosenbaum DM, Kobilka TS, Thian FS, Edwards PC, Burghammer M, Ratnala VR, Sanishvili R, Fischetti RF, Schertler GF, Weis WI, Kobilka BK. (2007) Crystal structure of the human beta2 adrenergic G-protein-coupled receptor. Nature 450: 383-387.
39. Kleymann G, Ostermeier C, Ludwig B, Skerra A, Michel H (1995) Engineered Fv fragments as a tool for the one-step purification, of integral multisubunit membrane protein complexes. Biotechnology (N Y) 13:155-160.
40. Brown K, Nurizzo D, Besson S, Shepard W, Moura J, Moura I, Tegoni M, Cambillau C (1999) MAD structure of Pseudomonas náutica dimeric cytochrome 0(552) mimicks the c(4) dihemic cytochrome domain association. J Mol Biol 289:1017-1028.
41. Thorndycroft FH, Butland G, Richardson DJ, Watmough NJ (2007) A new assay for nitric oxide reductase reveals two conserved glutamate residues form the entrance to a proton-conducting channel in the bacterial enzyme. Biochem J 401:111-119.
42. Gramm R, Pohlmann A, Friedrich B (1999) Purification and characterization of the single-component nitric oxide reductase from Ralstonia eutropha H16. FEBS Lett 460: 6-10.
43. Prudêncio M, Pereira AS, Tavares P, Besson S, Cabrito I, Brown K, Samyn B, Devreese B, Van Beeumen J, Rusnak F, Fauque G, Moura JJ, Tegoni M, Cambillau C, Moura I. (2000) Purification, characterization, and preliminary crystallographic study of copper-containing nitrous oxide reductase from. Pseudomonas nautica 617. Biochemistry 39:3899-3907.
44. Saerens D, Kinne J, Bosnians E, Wernery U, Muyldermans S, Conrath K (2004) Single domain antibodies derived from dromedary lymph node and peripheral blood lymphocytes sensing conformational variants of prostate-specific antigen. J Biol Chem 279:51965-51972.
45. Arbabi Ghahroudi M, Desmyter A, Wyns L, Hamers R, Muyldermans S (1997) Selection and identification of single domain antibody fragments from camel, heavy-chain antibodies. FEBS Lett 414:521-526.
46. Lauwereys M, Arbabi Ghahroudi M, Desmyter A, Kinne J, Holzer W, De Genst E, Wyns L, Muyldermans S (1998) Potent enzyme inhibitors derived from dromedary heavychain antibodies. EMBO J 17:3512-3520.
47. Skerra A, Pluckthun A (1988) Assembly of a functional immunoglobulin. Fv fragment in Escherichia coli. Science 240:1038-1041.